HC Wainwright reaffirmed their buy rating on shares of Enlivex Therapeutics (NASDAQ:ENLV – Free Report) in a report issued on Tuesday morning, Benzinga reports. HC Wainwright currently has a $7.00 target price on the stock. Enlivex Therapeutics Stock Down 3.3 % Enlivex Therapeutics stock opened at $1.45 on Tuesday. Enlivex Therapeutics has a one year […]
Related Keywords
, Enlivex Therapeutics Ltd , Enlivex Therapeutics Company Profile , Enlivex Therapeutics , Free Report , Therapeutics Stock Down , Get Free Report , Enlivex Therapeutics Daily , Nasdaq Enlv , Enlv , Medical , Reiterated Rating , Hc Wainwright ,
comparemela.com © 2020. All Rights Reserved.